
Anupam Rasayan completes the Bliss GVS purchase: ₹299 a share for 48.2%, funded mostly by outside investors
Anupam Rasayan · Bliss GVS Pharma · acquisition
BSE: 543275
P/L Snapshot
Q1 FY27 · standalone
Shareholding
Pattern breakdown
P/L Trends
(in crores)

Anupam Rasayan · Bliss GVS Pharma · acquisition

platform diversification · Bliss pharma acquisition · ETFA flow chemistry

specialty chemicals · margin compression · finance cost surge
Corporate Events
Board Meeting
The 23rd Annual General Meeting will be held on September 30…
BSE Filing ↗Board Meeting
The Board of Directors approved the notice convening the 23r…
BSE Filing ↗Board Meeting
The meeting of the Board of Directors is scheduled to consid…
BSE Filing ↗Board Meeting
The board meeting is scheduled to consider and approve the A…
BSE Filing ↗Board Meeting
Approval of acquisition of Monitchem Kansas S.a r.l and its …
BSE Filing ↗Board Meeting
Approval of appointment of Mr. Milind Madan Talathi as Non-E…
BSE Filing ↗Board Meeting
Approved the appointment of Mr. Ketan Paragji Desai, Gen. Bi…
BSE Filing ↗Board Meeting
Consider and approve Audited Standalone and Consolidated Fin…
BSE Filing ↗Board Meeting
Consider and approve Unaudited Financial Results (Standalone…
BSE Filing ↗